Identifying Plasma Proteins for Hypertrophic Cardiomyopathy Penetrance and Severity in Pathogenic Variant Carriers and Noncarriers

Read full text Summarise with VIRAT
Authors: Fahima Hassanzada, Marion van Vugt, M. Jansen, Annette F. Baas, Anneline S.J.M. te Riele, Dennis Dooijes, Saskia N. van der Crabben, Jan D.H. Jongbloed, Moniek G.P.J. Cox, Ahmad S. Amin, Ronald H. Lekanne Deprez, Bram Ruijsink
+7 more Diederik W.D. Kuster, Jolanda van der Velden, Connie R. Bezzina, Folkert Wouter Asselbergs, J. Peter van Tintelen, Karin Y. van Spaendonck‐Zwarts, Amand Floriaan Schmidt
Cited by: 0
References: 46

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background Hypertrophic cardiomyopathy (HCM) is a clinically variable disease in terms of onset and progression. Pathogenic MYBPC3 variants account for a substantial proportion of HCM diagnoses. This study sought to identify protein biomarkers associated with HCM severity. Methods Olink-assayed plasma proteins of 144 MYBPC3 pathogenic variant carriers were tested for associations with HCM severity based on HCM diagnostic criteria (unaffected, mildly, or severely affected). The UK Biobank was used to replicate the identified proteins through considering time to onset of HCM (67 cases), cardiomyopathy (156 cases),and associations with cardiac MRI derived left ventricular maximum wall thickness (6,492 participants). Replicated proteins were further prioritised based on cardiac tissue expression and druggability, and annotated using pathway enrichment and association with onset of: heart failure (HF), dilated cardiomyopathy (DCM), sudden cardiac arrest (SCA), and ventricular arrhythmias (VA). Results Among pathogenic MYBPC3 variant carriers, we identified 27 proteins associated with HCM severity. We independently replicated 21 proteins in the UK Biobank. Of the five prioritised proteins (NT-proBNP, GDF-15, FGF-23, ADM, and NCAM1), all but NT-proBNP were targeted by drugs with repurposing potential. The replicated proteins additionally associated with the incidence of HF (n=5), DCM (n=4), SCA (n=4), and VA (n=4). Conclusion This study replicated 21 and prioritised five proteins associated with HCM severity in pathogenic MYBPC3 variant carriers. Replication in unselected HCM suggests the prioritised proteins are associated with HCM independent of genotype, providing important leads for plasma-based markers for diagnoses, disease monitoring, and drug targets.

Fields of Study & Subjects

Cardiomyopathy and Myosin Studies Cardiovascular Effects of Exercise Cardiac electrophysiology and arrhythmias

Publication details

Journal / source
JACC Advances
Volume
5
Issue
12
Pages
103457–103457
Publication date
17 November 2026
Language
EN